Various rat cell lines have been analyzed for expression of endogenous RNA homologous either to RT21C, a typical rat type C virus, or to Kirsten sarcoma virus. Cells have been found that express either (i) high levels of RNA homologous to RT21C rat type C virus and low levels of RNA homologous to Kirsten sarcoma virus (RT2lChigh,sarclow) or (ii) high levels of RNA homologous to Kirsten sarcoma virus and low levels of RNA homologous to typical rat type C virus (sarchigh,RT21C1w'). The properties of these two classes of cell lines have been compared. Each type of cell contains an equal amount of the expressed RNA on polysomes. Cell lines that are RT21Chigh produce abundant rat p30 and p12 structural proteins and release rat type C particles containing viral RNA and reverse transcriptase into supernatant fluids from these cultures. Cell lines that are sarchigh,RT21CIO'°' have no detectable rat viral p12 protein and no p30 protein immunoreactive in even broad interspecies radioimmunoassays, and do not release type C particles into the supernatant from the cultures. When the particle-negative cell lines are superinfected with heterologous mouse or woolly type C viruses or are producing typical rat type C virus particles, the endogenous sarcoma virus-specific RNA is secreted from these cells. The sarcoma virusspecific RNA can be transcribed in complementary DNA in endogenous reverse transcriptase reactions carried out in vitro with such virus preparations. However, exposure of cells that are permissive to the helper virus with the particles containing sarcoma virus-specific RNA has not yet resulted in cell transformation or in the synthesis of these RNA sequences. The results suggest: (i) that the first step in the genesis of sarcoma viruses involves the packaging of this expressed sarcoma virus-specific RNA in helper viral particles; (ii) that efficient transmission of the sarcoma virus-specific RNA requires additional events; and (iii) that the formation of a stable sarcoma virus by recombination between the helper viral genome and part of the rescued sarcoma virus-specific RNA is a much less common event than the rescue process itself.
Various rat cell lines have been analyzed for expression of endogenous RNA homologous either to RT21C, a typical rat type C virus, or to Kirsten sarcoma virus. Cells have been found that express either (i) high levels of RNA homologous to RT21C rat type C virus and low levels of RNA homologous to Kirsten sarcoma virus (RT2lChigh,sarclow) or (ii) high levels of RNA homologous to Kirsten sarcoma virus and low levels of RNA homologous to typical rat type C virus (sarchigh,RT21C1w'). The properties of these two classes of cell lines have been compared. Each type of cell contains an equal amount of the expressed RNA on polysomes. Cell lines that are RT21Chigh produce abundant rat p30 and p12 structural proteins and release rat type C particles containing viral RNA and reverse transcriptase into supernatant fluids from these cultures. Cell lines that are sarchigh,RT21CIO'°' have no detectable rat viral p12 protein and no p30 protein immunoreactive in even broad interspecies radioimmunoassays, and do not release type C particles into the supernatant from the cultures. When the particle-negative cell lines are superinfected with heterologous mouse or woolly type C viruses or are producing typical rat type C virus particles, the endogenous sarcoma virus-specific RNA is secreted from these cells. The sarcoma virusspecific RNA can be transcribed in complementary DNA in endogenous reverse transcriptase reactions carried out in vitro with such virus preparations. However, exposure of cells that are permissive to the helper virus with the particles containing sarcoma virus-specific RNA has not yet resulted in cell transformation or in the synthesis of these RNA sequences. The results suggest: (i) that the first step in the genesis of sarcoma viruses involves the packaging of this expressed sarcoma virus-specific RNA in helper viral particles; (ii) that efficient transmission of the sarcoma virus-specific RNA requires additional events; and (iii) that the formation of a stable sarcoma virus by recombination between the helper viral genome and part of the rescued sarcoma virus-specific RNA is a much less common event than the rescue process itself.
Two RNA-containing type C viruses with the ability to transform fibroblasts in cell culture have been isolated from rats. One of these, Kirsten sarcoma virus (KiSV), was formed by passage of Kirsten murine leukemia virus (KiMuLV) in Wistar-Furth (W/Fu) rats (13) . The other, Harvey sarcoma virus (HaSV), was formed by passage of Moloney leukemia virus in Chester Beatty rats (10) . In each case, the sarcoma virus has been found to be a recombinant between the mouse type C virus that was passaged in the rat and additional rat genetic information (1, 2, 16, 22, 25, 26) . Because the gain of rat genetic information by recombination (17) was accompanied in two independent cases by acquisition of the ability to transform fibroblasts in cell culture, earlier studies have focused on the characterization of the rat genetic sequences acquired in the recombination process. These studies revealed that many preparations of rat type C viruses contain two distinct sets of RNA sequences in varying proportions (23, 24) . Certain cultures, such as the RT21C rat cell line or a W/Fu rat cell line, released rat type C particles with a 50-to 100-fold excess of typical rat type C viral information as compared with the second set of sequences, C viral nucleic acid sequences and sarcoma virus-specific sequences. No cultures were found that produced a large excess of the sarcoma virus-specific sequences in the absence of the typical rat type C viral sequences (1, 23) .
In additional studies, the sarcoma virus-specific sequences were found to be present in multiple copies in several uninfected rat cellular DNAs (1, 22, 23) , to be inducible in certain cells with halogenated pyrimidines to high levels of expression (23) , and to be able to be specifically rescued by type C viruses that were released from the appropriate rat cell cultures (9, 23, 24) . Recently, Anderson and Robbins confirmed these observations and reported that a series of rat tumors had widely different levels of the two sets of sequences (1) .
The current studies have quantitated in several cell lines derived from rat tumors the relative levels of the sarcoma virus-specific RNA and the typical rat type C viral RNA in an effort to gain insight into the coding properties of the sarcoma virus-specific RNA. Cell lines have been found that produce: (i) low levels of either set of sequences; (ii) high levels of both sets of sequences; (iii) high levels of the sarcoma virus-specific RNA (sarchigh) and low levels of the rat type C viral RNA (RT21ClOW); and (iv) high levels of the rat type C viral RNA (RT21Chigh) and low levels of the sarcoma virusspecific RNA (sarciow). The properties of these different cell lines have been analyzed in detail, and the results indicate several important differences between sarchigh, RT21ClOw and sarclow, RT21Chigh cell lines.
MATERIALS AND METHODS Cells and viruses. The cells used were as follows. The normal rat kidney cell (NRK) line, derived from an Osborne-Mendel rat, has been previously described by Duc-Nguyen (5) . A uterine carcinoma cell induced by 7,12-dimethylbenzanthracene treatment of a Sprague-Dawley rat has been described by Sekiya et al. (27) and was the kind gift of S. Sekiya, Chiba, Japan. He has designated this cell HTP (27) , for "high tumor producing." WR123 cells, a fibroblast cell line derived from a testicular carcinoma of a Fisher rat, was the gift ofJack Parker of Microbiological Associates, Inc. This cell line was recently noted by Anderson and Robbins (1) to contain high levels of RNA homologous to KiSV. The IR162 fibroblast cell line was derived from a plasmacytoma from a Belgian rat. The plasmacytoma was the gift of Henry Metzger, National Institute of Arthritis, Metabolism, and Digestive Diseases. A fibroblast derived from a Fisher rat embryo, designated FRE clone 2, was the gift of Robert Huebner, National Cancer Institute. Two cell lines releasing rat type C virus, the RT21C cell line, derived from the thymus of an Osborne-Mendel rat, and the W/Fu cell line, derived from a Wistar-Furth rat, have been described (23, 24) .
A dog thymus cell line (Cf2th), a dog kidney culture (MDCK), and a mink lung fibroblast cell line were obtained from the American Type Culture Collection. A human tumor cell line, RD, derived from a human rhabdomyosarcoma, has been described by McAllister et al. (14) . A nonproducer mink cell transformed by KiSV has been previously described (11, 24) . A nonproducer dog kidney cell line transformed by HaSV virus was obtained by rescuing a rat cell nonproducer cell transformed by HaSV with an amphotropic strain of murine type C virus obtained from Janet Hartley, National Institute of Allergy and Infectious Diseases. The virus mixture released from the rat cells was transmitted to MDCK canine kidney cells, and nonproducer foci were obtained at limiting dilutions of the virus using Falcon Microtest II plates as previously described (2) . This cell line is referred to as Ha-dog clone 8.
Viruses. The sources of rat type C virus used in these experiments were either the RT21C cell line, the W/Fu cell line, or the V-NRK culture (24) . As previously described (23, 24) , the W/Fu and RT21C cultures release approximately a 50-fold excess of typical rat type C sequences over KiSV-homologous sequences; the V-NRK culture releases approximately equal quantities of the RT21C sequences and the KiSV-homologous sequences in the supernatant fluids from this cell. The woolly leukemia virus was obtained from the supernatant fluid of RD cells or from NC37 human lymphocytes (19) . An amphotropic strain of murine type C virus was obtained from Janet Hartley of the National Institute of Allergy and Infectious Diseases and is a mouse type C virus capable of growing in both NIH 3T3 cells and various nonmurine cells, and therefore has been designated as amphotropic. It was propagated in NIH 3T3 cells for preparation of the complementary DNAs (cDNAS) and in mink cells for the preparation of viral RNA. Another virus preparation, a pseudotype of KiSV, was obtained by rescuing the mink nonproducer of KiSV with a subgroup C strain of feline type C virus (FeLV) by procedures previously described (24) . This virus complex, KiSVFeLV, was used to prepare the KiSV-specific cDNA (24 (16) . The eluted samples were passed through a Gelman filter to remove solid acrylamide and then passed over a G-25 medium Sephadex column equilibrated in distilled water to remove watersoluble acrylamide. Samples were then lyophilized before use. Recovery of counts by either the hydrogen peroxide or the lithium chloride elution was over 60% of the counts initially applied to the gel.
Preparation of polysomes. Polysomes from HTP cells were prepared by a modification of procedures previously described (7) . Cells were scraped into cold phosphate-buffered saline and washed three times by resuspension and centrifugation in phosphatebuffered saline. They were then suspended in a buffer containing 0.025 M Tris-hydrochloride pH 7.6, 0.025 M sodium chloride, 0.005 M magnesium chloride, and 0.14 M sucrose (polysome buffer). Approximately 5 to 7 volumes of this buffer was used per ml of packed cells. To the cell suspension, both Triton X-100 and deoxycholate were added to a final concentration of 0.7% (vol/vol), and the cells were then homogenized with six strokes in a loose-fitting Dounce homogenizer. Nuclei were removed by centrifugation at 5,000 rpm for 5 min at 4°C, and 6.0 ml of the polysomes was collected by centrifugation in an SW41 rotor at 39,000 rpm for 16 h through a 4.0-ml column of 1.0 M sucrose onto a 2.0-ml 2.5 M sucrose cushion prepared in polysome buffer. The polysomes were aspirated from the 2.5 M sucrose cushion and passed over a Sepharose 4B column equilibrated in polysome buffer without sucrose in order to remove the sucrose. They were then spun in a 10 to 50% (wt/vol) sucrose gradient in an SW41 rotor at 15,000 rpm at 4°C for 16 to 18 h. Fractions of 0.5 ml were collected by puncturing the tubes from below. The optical density of each fraction was determined, and appropriate fractions were pooled as indicated later in Results. For treatment with EDTA, the Sepharose 4B fractions were first treated at 4°C for 10 min with 10-2 M EDTA and then spun on October 18, 2017 by guest http://jvi.asm.org/ Downloaded from VOL. 20, 1976 on the 10 to 50% sucrose gradient with parallel control preparations.
Radioimmunoassay of viral proteins. The p30 proteins of either RT21C virus or the Moloney strain of mouse type C virus, or the p12 protein of the RT21C rat virus, were purified by procedures previously described (19, 24) . The proteins were iodinated by the chloramine-T method to specific activities of between 5 x 103 to 2 x 104 cpm/,ug of protein. Double-antibody radioimmunoassays were performed in 0.50-ml reaction mixtures containing: 0.01 M potassium phosphate buffer, pH 7.4; 0.01% (vol/vol) Triton X-100 (TP buffer); 0.01 M EDTA; 0.02% (vol/vol) normal goat serum; and 200 u±g of bovine serum albumin per assay. All components used in the assay were diluted in TP buffer before use. The assay was initiated by adding to each tube 0.15 ml of TP buffer and 0.05 ml of unlabeled antigen followed by 0.10 ml of a primary antibody, noted in the appropriate legends. The primary antibody and putative competing antigen were incubated in this 0.3-ml volume at 370C for 2 h. A 10-ml aliquot of the iodinated antigen was then added to deliver approximately 50,000 cpm per assay. Reaction mixtures were then incubated for an additional hour at 370C. The last addition of 0.10 ml of second antibody was then made; the second antibody used in these experiments was pig anti-goat serum used at a 1:8 dilution in all assays. The reaction was incubated for an additional hour at 370C and then at 4°C for 12 to 16 h. The precipitate was recovered by centrifugation at 2,500 rpm at 4°C for 20 min. The supernatant was aspirated, and the pellets were washed at 4°C in buffer containing 0.1% Triton X-100, 0.05% (vol/vol) deoxycholate, 0.05 M Tris-hydrochloride, pH 7.5, 0.10 M sodium chloride, 10-3 M EDTA, and 0.05% (vol/vol) normal rabbit serum. The washed pellets were recentrifuged at 2,500 rpm at 40C for 20 min, and the pellets were counted in an LKB gamma counter. Competition assays were performed at dilutions of primary antibody that precipitated approximately 20 to 30% of a given iodinated antigen. The dilutions of primary antibody used against the different viral antigens are indicated in the legends to Fig. 2 cpm/,ug and with lOO1ng of unlabeled cDNA. Hybridization was also analyzed by using Si nuclease as fully detailed previously (24) .
Hybridization to viral RNA in the supernatant fluids from cell cultures was carried out as previously detailed and analyzed as a function of Vot (milliliters x hour) as suggested by Ringold et al. (21) . To ensure the comparability of experiments, identical numbers of cells were seeded in comparisons between supernatant fluids from different cells.
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RESULTS Cell lines with high KiSV-homologous RNA and low rat type C viral RNA. Several rat cells were examined for relative levels of RNA homologous to KiSV or RT21C rat virus. Three cell lines derived from different strains of rats were found to contain high levels of RNA homologous to KiSV and low levels of RNA homologous to RT21C rat virus. The results of RNA-[3H]DNA hybridization experiments performed on the total cellular RNA from such cells are shown in Fig. 1. In Fig. 1A , a uterine carcinoma cell, designated HTP, was analyzed for the relative levels of the two sets of sequences. Only low levels of the RT21C-like sequences were found in these cell lines, and the 1/2C,t was not achieved at levels of greater than 103 mol -s per liter. In contrast, the cells contained very high levels of KiSV-homologous sequences, with a 1/2Crt value of approximately 7 x 10 to 8 x 10 mol * s per liter. Similarly, a cell line derived from a testicular carcinoma of a Fisher rat, WR123, and a cell line derived from a plasmacytoma of a Belgian rat had low levels of the RT21C sequences and high levels of the sarcoma virus-specific sequences. The 1/2C,t value for the KiSV-homologous sequences in WR123 cells was approximately 100 to 200 mol s per liter, and for the IR162 cell it was approximately 200 mol s per liter. In contrast and as a reference for these cells, the results with RT21C cells are shown in Fig. 1B . As previously reported, these cells had low levels ofthe sarcoma virus-specific sequences but high levels of the typical rat type C viral nucleic acid sequences.
Importantly, the 1/2C7t value for the typical rat type C viral nucleic acid sequences in these cells was approximately 100 to 200 mol -s per liter, a value in close agreement with the values for the sarcoma virus-homologous RNA found in the HTP, WR123, and IR162 cells. In fact, the levels of the sarcoma virus-specific RNA in HTP cells were slightly greater than the levels of the typical rat type C viral sequences in RT21C cells.
Protein analysis of cell lines. The same four cell lines were analyzed for various structural proteins of mammalian type C viruses by competition radioimmunoassays (Fig. 2 and 3 ).
In Fig. 2 , the various rat cells were analyzed in competition radioimmunoassays in three separate radioimmunoassays for the p30 protein. In Fig. 2A , an assay is shown that demonstrates the radioimmunoassay between the iodinated rat p30 and a goat serum prepared against RT21C rat virus. In Fig. 2B , an interspecies assay is shown between an iodinated mouse p30 protein and a goat serum prepared against FeLV (19) . In Fig. 2C , an assay is shown be- in experiments not shown, with puromycin). The optical density seen in fractions 6 through 14 of Fig. 3 moved to the top of the tube in fractions 21 through 26.
The RNA from fractions 6 through 14 in the control gradient and in the EDTA-treated gradient, and the RNA in fractions 21 through 26 from each gradient, was analyzed with the sarcoma virus-specific cDNA for homologous sequences. The results of this hybridization analysis are shown in Fig. 5 and plotted as a function of RNA concentration and time. Fractions 6 through 14 from the control gradient had high levels of the sarcoma virus-specific RNA with a '/2Crt value of approximately 100 mol *s per liter. In the gradient treated with EDTA, a drastic reduction in the levels of the sarcoma virus- tectable immunoreactive proteins, the RNA from these cells was analyzed to see whether it was present on polysomes in HTP cells. In parallel experiments, the RNA from RT21C cells was analyzed to see whether it was on polysomes. A typical polysome profile prepared without and with treatment with EDTA is shown in Fig. 4 . A broad peak of optical density was seen in the dense region of the sucrose gradient; this peak disappeared after the polysomal preparation was treated with EDTA (or, (Fig. 6) tained only the RT21C sequences and peak 2 contained the sequences homologous to KiSV.
RNA rescued with heterologous type C viruses. To further identify the size of the KiSVspecific RNA, two of the cell lines indicated in Fig. 1 , namely the HTP cell and the WR123 cell lines, were superinfected with type C viruses not of rat origin. In the case of WR123 cells, an amphotropic strain of mouse type C virus was used because it grew readily in these cells, and in the case of HTP cells a strain of woolly leukemia virus was used because it grew readily in HTP cells. The supernatants from the uninfected and infected cells were analyzed for sarcoma virus-specific RNA to ascertain whether particles containing the RNA were being produced from these cells (Fig. 7A, B) . The uninfected WR123 cells failed to release sarcoma virus-homologous RNA sequences into the supernatant even at V0t values of 1,000 to 2,000 ml x h. In contrast, cells superinfected Aot (mIs-hrs)
The pellets were extracted by phenol and chloroform extraction for putative viral RNA in the presence of 50 pg ofyeast carrier RNA per ml (19 (Fig. 7B) . Again, no viral RNA was detected in supernatants from the uninfected HTP cells even at high Vot values. Again, the supernatant from the superinfected cell contained both the woolly leukemia sequences and the rescued sarcoma virus-homologous sequences. As in the WR123 culture, the woolly virus-producing HTP cells released approximately equal amounts of the woolly viral RNA and the sarcoma virus-specific RNA into the supernatant from the infected cells. Thus, neither the uninfected HTP cells nor the uninfected WR123 cells released the sarcoma virus-specific RNA in type C particles into the supernatant unless they were producing other type C viruses.
Ratios of helper sequences and rescued rat sequences. To further characterize the RNA rescued from Fisher rat cells with the amphotropic strain of murine type C virus, 32P-labeled 70S viral RNA was prepared from the amphotropic virus grown in mink cells and from the amphotropic virus grown in WR123 cells. Each of these RNAs was heat denatured and run in agarose-acrylamide gels for preparation of the viral subunits. In repeated studies not shown, we were unable to separate in 2.2 or 2.4% agarose-acrylamide gels the subunit of the amphotropic virus itself from the subunit of the rescued rat sequences even if the 70S RNA was denatured and applied in 50% formamide. Also, when gels were run for shorter times, no additional peaks were seen between 35S and 10S on the gels. Therefore, to prove that the 35S subunit obtained from the gels contained the rat sequences, we analyzed both the 70S RNA Reverse transcription of rescued rat sequences. To further evaluate the ratio of the rat and mouse sequences from Fisher rat cells superinfected with amphotropic virus and HTP cells superinfected with woolly helper virus, the virus preparations prepared from these cells were used to prepare tritiated cDNA's in endogenous reverse transcriptase reactions. The probes from these endogenous reactions and a probe from each helper virus grown in non-rat cells were analyzed by tritiated DNAexcess RNA hybridization until saturating values of hybridization were achieved with various viral 70S RNAs (Table 3 ). The cDNA from the amphotropic virus grown in NIH cells hybridized well to its homologous 70S RNA but did not hybridize to detectable levels to RNA from either the woolly virus grown in human cells or the RNA from V-NRK or RT21C virus. In contrast, the probe prepared from the amphotropic virus grown in Fisher rat cells hybridized equally well to the amphotropic viral RNA and the RNA from the V-NRK culture.
Similar results were also obtained with probe prepared from the woolly virus grown in HTP rat carcinoma cells. The probe from this viral preparation contained approximately equal quantities of rat and woolly virus information at saturation, whereas the woolly virus grown in human cells contained no detectable hybridization to the rat viral RNA. Thus, the results indicate (i) that virus preparations prepared from WR123 and HTP cells contain equal quantities of the helper RNA and the rescued sarcoma virus-specific RNA in these particles, and (ii) that the cDNA probes in vitro prepared from these particles also contain equal quantities of the helper sequences and the rescued rat sequences. We cannot be certain, however, whether the two RNAs are contained as heterodimers in single virus particles or homodimers in separate particles, or whether any recombination between the RNAs has occurred. An attempt was made to determine whether the rat sequences could be transmitted from either culture to a non-rat cell culture. The amphotropic viral preparation with the 1:1 ratio was transmitted to mink cells, which are highly permissive for growth of the amphotropic virus, and the woolly viral preparation was transmitted to RD cells, which are highly permissive for it. In each case, after approximately 12 cell passages, RNA homologous to the helper virus could easily be detected at a Crt value of 10 mol -s per liter in infected cultures. However, in neither case could we detect sarcoma virus-specific RNA in the transmitted cells at Crt values of 20,000 mol s per liter, even though the virus preparations used in the transmission contained equal quantities of helper RNA and rescued sarcoma virus-specific RNA and even though in in vitro reverse transcriptase reactions equal proportions of the helper virus and sarcoma virus-homologous RNA were transcribed.
Summary of properties of rat cells. A summary of the properties of the rat cells with varying levels of expression of endogenous rat RNAs is shown in Table 4 (1, 16, (22) (23) (24) (25) (26) 28) . A plausible hypothesis has seemed to be that the acquired rat genetic information coded for the function(s) that endowed these viruses with the ability to produce malignant transformation (1, 26) . Thus, characterization of the properties of the rat-derived RNA and of cells producing the endogenous sarcoma virus-specific RNA has been undertaken. Earlier studies have indicated that the sarcoma virus-specific RNA shared three properties with known mammalian type C viruses: (i) presence in multiple copies in uninfected rat cellular DNA; (ii) inducibility with halogenated pyrimidines; and (iii) ability to be specifically rescued by type C viral particles produced from cells expressing the sarcoma virus-specific RNA (9, 23) . These and earlier studies (1, 28) indicate that the size of the sarcoma virus-specific RNA is comparable to that of the subunit of the RT21C rat type C virus or the subunit of an amphotropic strain of mouse type C virus. Thus, by a fourth criterion, size, the sarcoma virus-specific RNA is similar in properties to typical mammalian type C viral RNA. Furthermore, since the endogenous sarcoma-specific RNA is larger than Harvey sarcoma virus (16) , the results indicate that only a portion of the endogenous genome has been incorporated into the stable sarcoma virus.
In contrast to these similarities between endogenous sarcoma-specific RNA and type C viral sequences, the current studies have revealed significant differences in cells producing high levels of the respective RNAs. Cells producing high levels of typical type C viral RNA produce structural proteins that cross-react in assays for rat p12 and mammalian p30 radioimmunoassays. Supernatants from such cells produce type C particles containing viral reverse transcriptase and viral RNA. In contrast, four cell lines producing high levels of the sarcoma virus-specific RNA produce no p30 protein detectable even in broadly reacting p30 assays, no rat p12 protein, and no type C particles containing viral RNA or polymerase. Since we have not been able to purify the rat viral glycoprotein, we cannot exclude the possibility that the sarcoma virus-specific RNA codes for this protein. However, since the sarcoma virus-homologous RNA does not code for either the RT21C viral polymerase or gag protein, since it lacks homology to typical RT21C rat type C RNA, the possibility that the sarcoma virus RNA codes for the RT21C coat protein seems remote.
The absence of immunoreactive proteins cannot be explained by the RNA not being on polysomes, since both RT21C and HTP cells contained comparable amounts of their respective RNAs on polysomes of each cell. These results leave four main possibilities as the explanation of the results. Proteins might be produced and rapidly degraded and thus not be detectable. Protein precursors might be made which are not cleaved and lack determinants detectable in the assays used. Although the RNA is on polysomes, it may not be translated as an endogenous sequence. Or the class of "type C-like" RNA may code for a class of proteins that do not immunologically cross-react with the proteins of the known class of particleproducing mammalian type C viruses. The implications of these alternatives are important to an explanation of the genesis of Kirsten or Harvey sarcoma virus. The first three alternatives might imply that the combination of the rat sequences and mouse viral sequences of KiSV or HaSV would allow protein(s) to be made or to accumulate in cells infected with these viruses that do not usually occur when the sarcoma virus sequences are endogenous. The fourth alternative would imply that this sarcoma virus RNA might code directly for protein(s) responsible for transformation even when expressed in uninfected rat cells. If this last alternative is true, then virus stocks obtained from either WR123 or HTP cells with a 1:1 ratio of helper virus RNA and the rescued endogenous sarcoma-specific RNA should be useful in identifying the coding functions of the RNA. Since the 5' end of type C viral RNA apparently can be translated in vitro (12, 16, 29) , it may be possible to use such stocks to identify proteins coded for by the 5' end of this endogenous sarcoma virus-specific RNA.
Finally, the studies on the sarcoma virusspecific RNA in NRK cells (1, 23, 24) and now in HTP and WR123 cells suggest the following events in the genesis of a sarcoma virus: (i) expression of endogenous sarcoma virus-specific RNA and (ii) packaging of this RNA in heterologous viruses grown in these cells. Since reverse transcription of the RNA can occur in vitro, it will be of interest to follow the potential in vivo reverse transcription and later steps in the replicative cycle of the helper particles with the rescued sarcoma virus sequences when they are transmitted to new cells. Such studies should be useful in unraveling the genesis of sarcoma viruses, since the current studies clearly demonstrate that either synthesis, integration, or transcription of this DNA in newly infected cells must be a less common event, and probably the rate-limiting step in the genesis of a sarcoma virus. However, again, with stocks of virus such as those described herein with a 1:1 ratio of helper viral RNA and endogenous sarcoma virus-specific RNA, it may be possible to identify the rate-limiting step in formation of a sarcoma virus in cell culture.
